GILD: Message Board for Gilead Sciences, Inc. - InvestorVillage


Gilead Sciences, Inc.

  GILD website

GILD   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
12063 Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer GN jerrykrause 0 1/11/2022 7:11:16 PM
12062 Gilead Sciences Announces Results of Phase 3 Study of Remdesivir for COVID-19 Treatment GN jerrykrause 1 1/6/2022 7:49:45 PM
12061 Re: Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns GN CalaverasCounty 1 12/24/2021 5:12:21 PM
12060 Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns GN jerrykrause 0 12/24/2021 3:06:54 PM
12059 Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration GN jerrykrause 0 12/24/2021 3:05:59 PM
12058 Gilead's Remdesivir Covid-19 Therapy Cuts Risk of Hospitalization in Study; Gilead to ask U.S. health regulators to expand the drug's use to keep people out of the hospital GN jerrykrause 0 12/22/2021 9:26:52 PM
12057 Kite claims a first for CAR-T Tecartus in adult leukaemia GN jerrykrause 0 10/5/2021 6:13:30 PM
12056 Gilead reports positive results from Phase III remdesivir trial GN jerrykrause 0 9/24/2021 12:59:19 PM
12055 Remdesivir reduces mortality by 40% in Covid-19 patients, study finds GN jerrykrause 1 8/21/2021 11:48:45 AM
12054 Maintaining Our $81 Gilead FVE; HIV in Recovery; Key Oncology Data Approaches GN jerrykrause 0 7/31/2021 11:10:07 AM
Previous 2500 Messages Top of Message List Post Message Go to Msg #  


Financial Market Data provided by
.
Loading...